Drug-resistant infantile spasms with focal onset in encephalocraniocutaneous lipomatosis harboring a somatic mosaic KRAS mutation: a case report and literature review
Frontiers in Pediatrics · 10.11.2026 · 14
DOI: 10.3389/fped.2026.1958767 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 10.11.2026. Verfasst von Kai Peng und 5 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Encephalocraniocutaneous lipomatosis (ECCL) is a rare neurocutaneous syndrome. The diagnostic detection rate of somatic mosaic KRAS mutations in ECCL has increased with the implementation of high-depth tissue next-generation sequencing (NGS). However, the electroclinical features of seizures and anti-seizure medication (ASM) responses in this subtype remain poorly characterized. Case presentation We report a 10-month-old female infant presenting with the classic ECCL triad: nevus psiloliparus, ocular choristoma, and right cerebral hemispheric dysplasia. She developed frequent epileptic spasms starting at 3 months of age, consistent with a Developmental and Epileptic Encephalopathy (DEE). Video-EEG captured focal-onset spasms with right-hemisphere-predominant electrographic abnormalities. The patient exhibited a suboptimal response to a prolonged trial of first-line hormonal therapy (2-week ACTH followed by a 3-month oral prednisone taper) and subsequent multiple antiseizure medications (ASMs), fulfilling the International League Against Epilepsy (ILAE) criteria for Drug-Resistant Epilepsy (DRE). High-depth whole-exome sequencing (mean depth 150.85×) of the lesional skin tissue confirmed a somatic mosaic KRAS c.35G > A (p.Gly12Asp) mutation (variant allele frequency [VAF] of 19%), while peripheral blood testing was negative.
Conclusion
This case expands the electroclinical phenotype of KRAS -related ECCL to include focal-onset epileptic spasms within a DEE framework. It highlights a critical diagnostic pitfall: low systemic mosaic burden frequently leads to false-negative peripheral blood genetic tests. Therefore, high-depth sequencing of affected lesional tissue is mandatory for definitive diagnosis when clinical suspicion remains high.
Zitieren
APA
Peng, K., Zhao, L., Yan, H., Zhang, P., Li, H., & Guo, J. (2026). Drug-resistant infantile spasms with focal onset in encephalocraniocutaneous lipomatosis harboring a somatic mosaic KRAS mutation: a case report and literature review. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1958767
Vancouver
Peng K, Zhao L, Yan H, Zhang P, Li H, Guo J. Drug-resistant infantile spasms with focal onset in encephalocraniocutaneous lipomatosis harboring a somatic mosaic KRAS mutation: a case report and literature review. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1958767
BibTeX
@article{Peng2026,
author = {Peng, Kai and Zhao, Liming and Yan, Hongjun and Zhang, Peiqi and Li, Hua and Guo, Jing},
title = {Drug-resistant infantile spasms with focal onset in encephalocraniocutaneous lipomatosis harboring a somatic mosaic KRAS mutation: a case report and literature review},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1958767}
}
EUVIMED